Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
2’003 DKK | -0.45% | +1.91% | -7.05% |
03.05. | GENMAB : Guter Start ins Jahr 2024; Prognose unverändert | |
03.05. | Genmab steigert Nettogewinn in Q1; Umsatz springt | MT |
ETFs investiert in Genmab A/S
Name | Gewichtung | Volumen | % 1. Jan. | Investm. Rating |
---|---|---|---|---|
3,64% | 0 M€ | +15.90% | ||
1,28% | 0 M€ | +8.43% | ||
1,01% | 0 M€ | +0.24% | ||
0,75% | 0 M€ | +5.54% | - | |
0,56% | 0 M€ | +8.02% | ||
0,49% | 88 M€ | +10.37% | - | |
0,45% | 0 M€ | +3.13% | - | |
0,33% | 6 M€ | -.--% | - | |
0,33% | 4 M€ | -.--% | - | |
0,32% | 0 M€ | +2.74% | - | |
0,31% | 6 M€ | -.--% | ||
0,29% | 2 M€ | -.--% | - | |
0,29% | 2 M€ | +9.19% | - | |
0,24% | 29 M€ | +8.37% | - | |
0,20% | 0 M€ | +4.65% | - | |
0,19% | 0 M€ | +0.99% | - | |
0,14% | 3 859 M€ | +18.82% | - | |
0,14% | 469 M€ | -2.05% | - | |
0,14% | 10 M€ | -3.35% | - | |
0,09% | 276 M€ | +11.40% | - | |
0,08% | 0 M€ | -.--% | - | |
0,08% | 0 M€ | +8.31% | - | |
0,08% | 0 M€ | +11.06% | ||
0,07% | 7 M€ | +0.11% | - | |
0,06% | 0 M€ | 0.00% | - | |
0,04% | 0 M€ | +17.73% | ||
0,04% | 206 M€ | -.--% | ||
0,04% | 1 166 M€ | +0.26% | - | |
0,04% | 607 M€ | +0.05% | - | |
0,04% | 23 M€ | -.--% | - | |
0,04% | 786 M€ | -.--% |
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-7.05% | 18.64 Mrd. | |
+2.97% | 108 Mrd. | |
+10.21% | 105 Mrd. | |
+1.57% | 23.46 Mrd. | |
-12.77% | 21.72 Mrd. | |
-37.64% | 17.45 Mrd. | |
-6.50% | 17.19 Mrd. | |
+6.00% | 13.99 Mrd. | |
+37.20% | 12.53 Mrd. | |
+330.95% | 8.81 Mrd. |
- Börse
- Aktien
- 565131 Aktie
- ETFs Genmab A/S